艾美捷科技代理Helvetica Health Care品牌全系列产品

Helvetica Health Care是一家位于瑞士日内瓦的医疗保健公司，致力于通过创新的产品和技术来管理健康和提高生活质量。作为瑞士生物技术协会的成员，Helvetica Health Care通过了ISO 13485认证，在质量和创新方面坚持最高标准。涵盖各种质量控制和验证面板，适用于不同的分子测试平台和检测。这些产品有多种规格，可用于单一或多种分析物的检测，帮助实验室监控测试性能，确保测试的准确性和可靠性。其质量控制和验证组合可根据产品配置、填充量和分析物浓度进行定制，满足不同平台的需求。

▎Helvetica Health Care产品线

Helvetica Health Care公司的产品涵盖：抗体、生命科学产品、血液分离产品、临床/诊断样本、质控品与标准品、分子生物学产品、细胞因子与生长因子、ELISA试剂盒/Western印迹相关产品、微生物、氧化应激产品、诊断产品以及人血浆制品。

▎Helvetica Health Care部分产品列表

艾美捷科技特约代理BioPorto Diagnostics A/S公司产品。

BioPorto Diagnostics A/S公司成立于2001年，是丹麦一家专门生产抗体和基于抗体的各种生物产品的公司。BioPorto拥有Bioporto Diagnostics和Antibodyshop两个品牌，分别侧重于诊断试剂盒和抗体产品。在30多个国家有代理商，产品销售网络遍布全球，99%以上为出口销售。BioPorto Diagnostics旗下产品主要为几种临床快速诊断试剂盒，包括诊断早期急性肾损伤的NGAL ELISA kit，Gc-globulin ELISA kit ，评估原发性免疫缺陷的MBL Oligomer ELISA kit，同时还有相关其他种属的科研用试剂盒和抗原抗体。其最新推出的产品有检测人体血浆中的活性蛋白C-蛋白C抑制物(APC-PCI)复合物的APC-PCI ELISA kit，高纯度人IgE单克隆抗体，以及Glucagon-like peptide-1和Exendin-4相关的单抗。

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. We sell our products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.

QED Bioscience致力于为生物医药行业提供各类高品质抗体。

QED Bioscience has been designing and manufacturing antibodies for over 20 years, and throughout our history, our goals have remained unchanged: provide the best antibody products and services on the market and support our clients with the expertise and assistance they should expect from a full-spectrum antibody company like QED.

QED Bioscience develops novel monoclonal and polyclonal antibody products for our academic, biotechnology, diagnostic and pharmaceutical research clients. We develop these antibodies using the client’s small molecule, protein, or peptide targets, or by utilizing the target cDNA. We are a full-service corporation, and offer additional immunochemistry services such as purification and conjugation so that we can provide our clients with an antibody product that will work specifically within their system. We also develop monoclonal antibodies with pharmacological activity for enzyme neutralization and inhibition of receptor-ligand interactions, and anti-idiotypic antibodies.

QED Bioscience的主要产品包括：

Agriculture and Food Science Antibodies

Anti-Immunoglobulin Antibodies

Apoptosis Antibodies

Autophagy Antibodies

BioWarfare Antibodies

Cancer Research Antibodies

Cell Adhesion Molecule Antibodies

Coagulation Factor Antibodies

DNA/RNA/Oxidative Stress Antibodies

Drug Antibodies

Enzymes and Enzyme Inhibitor Antibodies

Epitope Tag Antibodies

Growth Factors/Cytokines/Receptor Antibodies

Heat Shock and Stress Protein Antibodies

Hormones and Serum Protein Antibodies

Infectious Disease Antibodies

Ion Channel Antibodies

Matrix Protein/MMP Antibodies

Neuroscience and Signal Transduction Antibodies

Phospho-specific Antibodies

Protein Transcription Antibodies

Reproductive Biology Antibodies

Secondary Antibodies

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。

DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.

Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.

The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Diacron品牌全系列产品

Diacron是一个在人类、兽医和农业食品领域拥有30多年研究和诊断经验的企业。由Mauro Carratelli创建，以CARR测量单位闻名，专注于测量导致老化的氧化过程。开发了创新的测量方法，用于评估氧化应激和农业食品参数，其测试和仪器被广泛应用于氧化剂和抗氧化剂的监测，服务于研究和医学以及农业食品领域的专业人员，在1800多项科学研究中被使用，并以提供科学和技术援助而著称。作为意大利和全球知名的研究中心、实验室和医学专家的官方供应商，还通过了ISO 13485: 2016和ISO 9001: 2015认证，确保高质量的医疗器械生产和产品设计。其产品主要面向农业食品和人类兽医领域。

● 农业食品部门：生产用于化学分析的仪器和试剂，特别适用于葡萄酒、葡萄汁、油、醋和干果生产链中参数的光度法分析。目标客户包括小型和大型生产商、酿酒师和专业人士，为生产过程提供支持。

● 人类和兽医部门：参与生产用于自由基和抗氧化剂生化分析的试剂和仪器，面向在人类和兽医领域的研究和临床环境中工作的专业人士。

▍Diacron产品列表

Chem Service公司成立于1962年，专注于制造高品质、高纯度的标准物质。

Established in 1962, Chem Service is accredited to ISO Guide 34:2009, ISO/IEC 17025:2005, and registered and certified to the ISO 9001:2008 Quality Management System for the design, development, production, distribution, and servicing of organic neat and synthetic reference materials.

Chem Service, Inc. produces high purity standards for use as reference materials and for other laboratory purposes. More than 95% of our Standards Grade materials have a certified purity of 98.0% or greater and do not require purity corrections when preparing solutions for use with EPA, USTM, UST, and numerous other international methods. You can trust that our high purity standards are a quality product.

Standards Grade chemicals are clearly labeled with an expiration date that is based on years of experience in handling and testing. Products are packaged in small quantities to minimize storage, waste, and disposal requirements. Organic and inorganic chemicals, solutions, and mixtures are available to meet a wide range of specialized laboratory needs.

GenWay公司是为了探索和开发人类蛋白组而成立的。公司的总任务就是用基因特异性抗体來筛选和鉴定新蛋白、其功能及其编码基因，旨在成为以抗体介导的蛋白组研发的领域先锋。基因纬公司已成功地发展出一套有自己知识产权的、新穎、高效、低耗、高筛选通量的鉴定方法――抗体介导的蛋白和基因鉴定。公司提供大量的高质量的蛋白和相应的鸡抗体产品，是蛋白质组学研究的重要工具和有力助手。

As a leading protein and antibody solutions provider, GenWay has a proprietary technology platform and an international network to provide our clients with solutions and applications for proteins, antibodies, assays, and cell lines. We specialize in recombinant proteins and domain-specific IgY (chicken) antibodies and their applications, such as Seppro® products and difficult-to-express proteins. GenWay’s technology and expertise make high-quality protein antigens that enable production of high-quality antibodies and related applications.

GenWay Biotech的主要产品包括：

Proteins

Antibodies

ELISA Kits

Secondary Antibodies

Reagents

Peptides

Molecular Biology Products

Active Proteins

Enzymatic Assays

PCR Kits

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Absolute Antibody重组抗体。

Absolute Antibody成立于2012年，其产品线100%专注于重组抗体。虽然重组抗体是制药行业的主流，但这些抗体尚未广泛用于诊断或研究。由于重组抗体比传统杂交瘤产生的单克隆抗体

具有许多优势，这种情况正在开始改变。

Absolute Antibody专注于抗体测序、抗体工程和抗体重组表达，并提供定制服务、重组抗体和Fc融合蛋白。Absolute Antibody的客户包括制药公司、生物技术和诊断公司，以及世界各

地的学术研究人员。此外，Absolute Antibody团队在治疗性抗体和重组表达技术领域拥有丰富的经验。自成立以来，Absolute Antibody已生产了180多种不同构型的抗体，并开发了逾

15000种重组抗体试剂。

艾美捷科技代理Screenfect品牌全系列产品

ScreenFect GmbH成立于2012年，是一家专注于细胞转染技术创新的德国生物技术公司。ScreenFect®转染试剂是该公司的核心产品，是依托组合化学方法构建独特化学文库，通过高通量细胞筛选平台高效开发的转染试剂。ScreenFect®转染试剂适用于多种核酸分子（包括pDNA、siRNA、mRNA、miRNA）的单转染与共转染，在难转染细胞（如原代细胞、干细胞）中具有优异性能。

▎ScreenFect®转染试剂

● ScreenFect®A是一款通用型转染试剂，适用于pDNA、siRNA、mRNA的递送以及共转染实验，可广泛应用于多种细胞系（如HEK、HeLa、MEF）及部分原代细胞系。高效转染：在96孔板中仅需低于100ng DNA即可实现高转染效率。

● ScreenFect®siRN 是转染小干扰RNA双链体的理想选择，适用于HEK、HeLa、MEF等标准哺乳动物细胞系及多种原代细胞系。

● ScreenFect®mRNA是专为mRNA转染优化的高效试剂。

● ScreenFect®A-plus是一款多功能增强型转染试剂，适用于pDNA、siRNA、mRNA的转染及共转染实验，在几乎所有细胞系（包括难转染细胞）中均能实现高效转染。

ScreenFect®转染试剂具有以下特点：

● 低细胞毒性：显著降低对细胞活性的影响

● 省时一步法：支持细胞铺板与转染同步操作（即用型方案）

● 快速优化：针对新用户/新细胞系提供简易优化流程

● 血清兼容性：无需更换培养基，可直接在含血清环境下使用

● 无动物源成分：杜绝动物源性物质污染风险

● 高通量适用：完美适配大规模筛选实验需求

▎ScreenFect®UP-293

ScreenFect®UP-293 是一款专为高效生产抗体及蛋白设计的转染试剂，适用于HEK 293-F悬浮细胞体系。配合ScreenFect®Booster增效剂使用，可最大化提升悬浮细胞中的蛋白产量。

▎ScreenFect®Booster

在完成HEK293F悬浮细胞的ScreenFect®UP-293转染后，于转染后16小时添加ScreenFect®Booster增效剂，可显著提升蛋白产量。该增效剂含特定复合组分，通过重编程细胞代谢路径（从增殖模式转向蛋白合成模式），从而高效提升大多数目标蛋白的表达水平。

艾美捷科技代理Absolute Antibody重组抗体。

Absolute Antibody成立于2012年，其产品线100%专注于重组抗体。虽然重组抗体是制药行业的主流，但这些抗体尚未广泛用于诊断或研究。由于重组抗体比传统杂交瘤产生的单克隆抗体

具有许多优势，这种情况正在开始改变。

Absolute Antibody专注于抗体测序、抗体工程和抗体重组表达，并提供定制服务、重组抗体和Fc融合蛋白。Absolute Antibody的客户包括制药公司、生物技术和诊断公司，以及世界各

地的学术研究人员。此外，Absolute Antibody团队在治疗性抗体和重组表达技术领域拥有丰富的经验。自成立以来，Absolute Antibody已生产了180多种不同构型的抗体，并开发了逾

15000种重组抗体试剂。